Bullish
Corvus Pharmaceuticals (NASDAQ:CRVS) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen has upgraded Corvus Pharmaceuticals (NASDAQ:CRVS) from a "sell" to a "hold" rating. The company currently holds a "Moderate Buy" conse...